The premixed embolic agent is designed to embolize hypervascular tumors and occlude blood flow in a patient's peripheral blood vessels. It was recalled in April due to safety concerns.

The news comes just days after CMS confirmed these technologies would start receiving expanded Medicare coverage in November. HeartFlow and other AI vendors have already shared their excitement over the decision. 

The software is a collaboration between Bracco Diagnostics, a subsidiary of Bracco Imaging, and Subtle Medical, Inc.

The supply of Mo-99 and Tc-99m—the most commonly utilized medical isotopes in the world—could be cut by as much as 40% until the reactor in the Netherlands is up and running again.

By reducing report variability, the software could help decrease unnecessary biopsies in patients with questionable lesions.

The impending shortage pertains to molybdenum-99, or Mo-99. A structural issue has occurred with a pipe within the high-flux reactor in Petten, Netherlands, which will require an immediate repair. 

Despite these incidents, CT continues to be the preferred imaging technology for patients with implantable or wearable medical devices.

In recent years, shear-wave elastography has emerged as an imaging option that can provide greater detail into tissue health. Experts recently found that it is especially beneficial for fetal exams.

Similar tools could have great utility in enhancing clinical workflows and improving the diagnosis of cerebral aneurysms, which can be deadly if ruptured.

Enlitic's Laitek acquisition revolutionizes imaging data migrations with standardization, enhancing data quality and PACS value. This approach corrects and consistently labels studies, simplifying configuration. It transforms the migration landscape. For more details visit enlitic.com